Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000885531 | SCV001028983 | likely benign | not provided | 2025-01-13 | criteria provided, single submitter | clinical testing | |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV002252265 | SCV002523458 | likely benign | See cases | 2020-01-17 | criteria provided, single submitter | clinical testing | ACMG classification criteria: BS1, BP4 |
Gene |
RCV000885531 | SCV003803339 | uncertain significance | not provided | 2023-02-07 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Breakthrough Genomics, |
RCV000885531 | SCV005217091 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004550037 | SCV004772358 | likely benign | LAMA1-related disorder | 2020-07-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |